Navigation Links
New Research Shows Effectiveness of Stereotactic Body Radiotherapy for Spinal Tumors

MIAMI, Aug. 17 /PRNewswire/ -- Stereotactic body radiotherapy (SBRT) is a highly effective alternative treatment for some cancer patients with spinal metastases, reported in new research from The University of Texas in Houston, according to James G. Schwade, M.D. Executive Director of the CyberKnife Centers of Miami and Palm Beach.


"This data confirms the established method of cancer treatment used on spinal tumors and other hard to reach areas of the body, due to the precisely targeted radiation dose and non-invasive nature of radiosurgery," said Dr. Schwade.

The study was presented at the American Association of Neurological Surgeons annual meeting in San Diego.

"SBRT offers patients a minimally invasive treatment option they previously did not have," said Dr. Eric L. Chang. "We are also able to offer patients a degree of pain control and to decrease their pain medications, minimizing the side effects from those medications."

In the study, researchers evaluated 121 cancer patients with metastases to the spine who underwent intensity-modulated, near simultaneous, CT image-guided SBRT, said Dr. Chang.

Researchers used a stereotactic body frame system consisting of a whole-body vacuum cushion and plastic fixation sheet used to immobilize patients for the treatment period, which lasts approximately one hour.

The team performed MR imaging of the spine within 30 days of patient enrollment, every three months for the first year and every six months after that. Patients also evaluated their own pain and other discomfort using instruments including the validated Brief Pain Inventory and the M.D. Anderson Symptom Inventory.

The CyberKnife Centers of Miami and Palm Beach serve the Palm Beach, Broward and Miami Dade County areas with outpatient facilities treating cancer patients with stereotactic radiosurgery utilizing the CyberKnife. For more information please visit or

SOURCE CyberKnife Centers of Miami and Palm Beach
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
2. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
3. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
4. Researchers at Cleveland Clinic Identify Site of Dysfunction in HDL, Carrier of Good Cholesterol
5. Video: New Research Discovers Independent Brain Networks Control Human Walking
6. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
7. Cleveland Clinic Researchers Identify Mechanism Behind Platelet Function and Potentially Fatal Blood Clot Formation
8. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
9. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
10. Researchers Identify Virus Possibly Responsible for Declining Honeybee Population Using 454 Sequencing Technology from Roche
11. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
Post Your Comments:
(Date:6/24/2016)... June 24, 2016  Collagen Matrix, Inc., ("Collagen ... and manufacturing of collagen and mineral based medical ... that Bill Messer has joined the ... further leverage the growing portfolio of oral surgery, ... Bill joins the Collagen Matrix executive team ...
(Date:6/24/2016)... 24, 2016 The Academy of Managed Care ... that would allow biopharmaceutical companies to more easily ... make formulary and coverage decisions, a move that addresses ... medicines. The recommendations address restrictions in the ... the drug label, a prohibition that hinders decision makers ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... , ... The temporary closing of Bruton Memorial Library on June 21 due to a possible ... often overlooked aspect of head lice: the parasite’s ability to live away from a human ... but a necessary one in the event that lice have simply gotten out of control. ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... On Friday, ... presented a Bronze Wellness at Work award to iHire in recognition of their exemplary ... part of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin ... companies that call for a minimum wage raise to $12 an hour by 2020 and ... This will restore the lost value of the minimum wage, assure the wage floor does ...
(Date:6/24/2016)... ... 2016 , ... Strategic Capital Partners, LLC (SCP) in concert ... capital for emerging technology companies. SCP has delivered investment events and professional ... than a million dollars of capital investment for five companies. The ...
Breaking Medicine News(10 mins):